Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro

Oncology Letters

Volumn 3, Issue 6, 2012, Pages 1263-1267

  Tong, Nannan ^a   Zhang, Jie ^b   Chen, Youran ^a   Li, Zhubo ^a   Luo, Yonghuang ^a   Zuo, Hua ^a   Zhao, Xiaoyan ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b CHONGQING THREE GORGES UNIVERSITY   (China)

Author keywords

A549; Berberine; Doxorubicin; HeLa; Synergistic effect

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACRIDINE; BERBERINE; DOXORUBICIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL ASSAY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; FLUORESCENCE MICROSCOPY; HEART PROTECTION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INCUBATION TIME; SENSITIZATION;

EID: 84859464708     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.644     Document Type: Article

References (29)

1. Henderson IC and Frei TE III: Adriamycin and the heart. N Engl J Med 300: 310-312, 1979.
2. Christiansen S and Autschbach R: Doxorubicin in experimental and clinical heart failure. Eur J Cardiothorac Surg 30: 611-616, 2006.
3. Binaschi M, Capranico G, Dal Bo L and Zunino F: Relationship between lethal effects and topoisomerase II mediated double-strand DNA breaks produced by anthracyclines with different sequence specificity. Mol Pharmacol 51: 1053-1059, 1997.
4. Hennig UG, Rudd NL and Hoar DI: Kinetochore immunofluorescence in micronuclei: a rapid method for the in situ detection of aneuploidy and chromosome breakage in human fibroblasts. Mutat Res 203: 405-414, 1988.
5. Boucek RJ Jr, Dodd DA, Atkinson JB, Oquist N and Olson RD: Contractile failure in chronic doxorubicin-induced cardiomyopathy. J Mol Cell Cardiol 29: 2631-2640, 1997.
6. Doroshow JH: Effect of anthracyline antibiotics on oxygen radical formation in rat heart. Cancer Res 43: 460-472, 1983.
7. Ichihara S, Yamada Y, Kawai Y, Osawa T, Furuhashi K, Duan Z and Ichihara G: Roles of oxidative stress and Akt signaling in doxorubicin cardiotoxicity. Biochem Biophys Res Commun 359: 27-33, 2007.
8. Temma K, Chugun A, Akera T, Hara Y, Sasaki T and Kondo H: Ca2+ overloading causes the negative inotropic effect of doxorubicin in myocytes isolated from guinea-pig hearts. Eur J Pharmacol 322: 235-242, 1997.
9. Timothy CB and Gregory SK: Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev 2: 94-102, 1997.
10. Takase H, Yamamoto K, Ito K and Yumioka E: Pharmacological studies on antidiarrheal effects of berberine and geranii herb. Nihon Yakurigaku Zasshi 102: 101-112, 1993 (In Japanese).
11. Iwazaki RS, Endo EH, Ueda-Nakamura T, Nakamura CV, Garcia LB and Filho BP: In vitro antifungal activity of the berberine and its synergism with fluconazole. Antonie Van Leeuwenhoek 97: 201-205, 2010.
12. Zhang H, Wei J, Xue R, et al: Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 59: 285-292, 2010.
13. Zhao X, Zhang JJ, Wang X, Bu XY, Lou YQ and Zhang GL: Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital- treated rats. Biomed Pharmacother 62: 567-572, 2008.
14. Janbaz KH and Gilani AH: Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents. Fitoterapia 71: 25-33, 2000.
15. Zhou JY, Zhou SW, Tang JL, Xu Y and Ying Y: Effect of berberine on Cdk9 and cyclin T1 expressions in myocardium of diabetic rats. J Med Coll PLA 23: 45-51, 2008.
16. Zeng XH, Zeng XJ and Li YY: Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92: 173-176, 2003.
17. Salehi S and Filtz TM: Berberine possesses muscarinic agonist-like properties in cultured rodent cardiomyocytes. Pharmacol Res 63: 335-340, 2011.
18. Patil JB, Kim J and Jayaprakasha GK: Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol 645: 70-78, 2010.
19. Kuo CL, Chou CC and Yung BY: Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett 93: 193-200, 1995.
20. Tsang CM, Lau EP, Di K, et al: Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med 24: 131-138, 2009.
21. Kim JB, Yu JH, Ko E, et al: The alkaloid berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine 17: 436-440, 2010.
22. Kheir MM, Wang YG, Hua L, Hu J, Li LL, Lei F and Du L: Acute toxicity of berberine and its correlation with the blood concentration in mice. Food Chem Toxicol 48: 1105-1110, 2010.
23. Chou TC and Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55, 1984.
24. Tallarida RJ: Drug synergism: Its detection and applications. J Pharmacol Exp Ther 298: 865-872, 2001.
25. Yoshida M, Shiojima I, Ikeda H and Komuro L: Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. J Mol Cell Cardiol 47: 698-705, 2009.
26. Peng PL, Hsieh YS, Wang CJ, Hsu JL and Chou FP: Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol Appl Pharmacol 214: 8-15, 2006.
27. Yan K, Zhang C, Feng J, et al: Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells. Eur J Pharmacol 661: 1-7, 2011.
28. Meeran SM, Katiyar S and Katiyar SK: Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol 229: 33-43, 2008.
29. Bliss CI: The toxicity of poisons applied jointly. Ann Appl Biol 26: 585-615, 1939.